Fibrosis in chronic hepatitis C acquired in infancy: Is it only a matter of time?

American Journal of Gastroenterology

Volumn 98, Issue 3, 2003, Pages 660-663

  Guido, Maria ^b   Bortolotti, Flavia ^b   Leandro, Gioacchino ^b   Jara, Paloma ^b   Hierro, Loreto ^b   Larrauri, Javier ^b   Barbera, Cristiana ^b   Giacchino, Raffaella ^b   Zancan, Lucia ^b   Balli, Fiorella ^b   Crivellaro, Carlo ^b   Cristina, Emilio ^b   Pucci, Angela ^b   Rugge, Massimo ^a  

^a Istituto di Anatomia Patologica   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANALYSIS; ARTICLE; ASSAY; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE DURATION; FEMALE; GENDER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INFANCY; LIVER BIOPSY; LIVER FIBROSIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PREDICTION; PRIORITY JOURNAL; STAGING; TIME; VIRUS INFECTION;

EID: 0037347034     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07293.x     Document Type: Article

References (17)

1. Poynard T, Bedossa P, Opolon P, for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC Groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
2. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A non-B hepatitis. N Engl J Med 1992;327:906-11.
3. Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332:1463-6.
4. Darby SC, Ewart DW, Giangrande PL, et al. Mortality from liver cancer and liver disease in haemophilic men and boys given blood products contaminated with hepatitis C. Lancet 1997;350:1425-31.
5. Dienstag JL. The natural history of chronic hepatitis C and what we should do about it. Gastroenterology 1997;112:651-5.
6. Niedearu C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C: Result of a large, prospective cohort study. Hepatology 1998;28:1687-95.
7. Hoshiyama A, Kimura A, Fujisawa T, et al. Clinical and histologic features of chronic hepatitis C virus infection after blood transfusion in Japanese children. Pediatrics 2000;105: 62-5.
8. Schwimmer JB, Balistreri WF. Transmission, natural history, and treatment of hepatitis C virus infection in the paediatric population. Semin Liv Dis 2000;1:37-46.
9. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999;341:866-70.
10. Guido M, Rugge M, Jara P, et al. Chronic hepatitis C in children: The pathological and clinical spectrum. Gastroenterology 1998;15:1525-9.
11. Kage M, Fujisawa T, Shiraki K, et al. Pathology of chronic hepatitis C in children. Hepatology 1997;26:771-5.
12. Badizadegan K, Jonas MM, Ott MJ, et al. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998;28:1416-23.
13. Tisminetzky S. Gerotto M, Pontisso P, et al. Comparison of genotyping and serotyping methods for the identification of hepatitis C virus types. J Virol Methods 1995;55:303-7.
14. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20: 15-20.
15. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
16. Poynard T, Ratziu V, Charlotte F, et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001;34:730-9.
17. Bortolotti F, Vairo P, Balli F, et al. Hepatitis C virus genotypes in chronic hepatitis C of children. J Viral Hepatol 1996;3: 323-7.